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The capability to take up mannosylated protein anti-
gens is important for the biologic function of dendri-
tic cells, as many glycoproteins derived from
bacteria and fungi, e.g., Malassezia furfur, are manno-
sylated. The expression of the mannose receptor
CD206 has been regarded a differentiation hallmark
of immature dendritic cells, whereas monocytes and
mature dendritic cells as well as epidermal
Langerhans cells do not express CD206. This study
describes some epidermal dendritic cells that may
express CD206 under in¯ammatory skin conditions:
Immunohistochemical and ¯ow cytometric analysis
with the CD206-speci®c D547 antibody con®rmed
that Langerhans cells from normal human skin do
not express CD206. Epidermal cell suspensions from
atopic dermatitis and psoriasis revealed two distinct
subsets of epidermal dendritic cells: a CD1a+++/
CD206± cell population (i.e., Langerhans cells) and a
CD1a+/CD206++ cell population, corresponding to
the previously described in¯ammatory dendritic epi-
dermal cells. CD206-mediated endocytosis, assessed
by dextran-¯uorescein isothiocyanate uptake, was
demonstrated in in¯ammatory dendritic epidermal
cells but not in Langerhans cells. CD206-independent
uptake of the ¯uorescent dye Lucifer yellow, a pino-
cytosis marker, was demonstrated in both
Langerhans cells and in¯ammatory dendritic epider-
mal cells. Electron microscopic examination, known
to distinguish Langerhans cells from in¯ammatory
dendritic epidermal cells by their Birbeck granules,
revealed Langerhans cells with Birbeck granules and
in¯ammatory dendritic epidermal cells without
Birbeck granules. In¯ammatory dendritic epidermal
cells exhibited numerous coated pits and vesicles, the
latter fusing with large endosome-like structures,
thus suggesting a high endocytotic activity.
Immunogold staining with D547 monoclonal anti-
body con®rmed that in¯ammatory dendritic epider-
mal cells were positive for CD206. In conclusion,
in¯ammatory dendritic epidermal cells but not
Langerhans cells are expressing CD206 in situ and use
it for receptor-mediated endocytosis. Key words: cellu-
lar differentiation/dendritic cells/¯uorescence-activated cell
sorter/human. J Invest Dermatol 118:327±334, 2002
D
endritic cells (DC) of the epidermis are assigned a
sentinel function of the cutaneous immune system
(Banchereau and Steinman, 1998; Bell et al, 1999). A
pathogenetic role has been assumed for these cells in
atopic dermatitis (AD), contact dermatitis, and some
other in¯ammatory skin diseases (Bieber, 1997). The uptake of
mannosylated protein antigens is important for the biologic
function of DC, as many glycoproteins, and especially those
derived from bacteria and fungi, are mannosylated (Buentke et al,
2000). To enhance the uptake and presentation of these ±
potentially dangerous ± mannosylated glycoproteins, some DC
use mannose-speci®c receptors for receptor-mediated endocytosis
and receptor-mediated facilitated antigen presentation.
The structure of the human mannose receptor CD206 (MR) was
resolved in 1990. It is a 175 kDa transmembrane glycoprotein
characterized by eight N-linked glycosylation sites and eight C-
type lectin carbohydrate recognition domains (Ezekowitz et al,
1990). Depending on the particle size and the cell type expressing
the MR, it may be involved in phagocytosis of mannose-coated
particles, in endocytosis of mannosylated glycoproteins or in
receptor-mediated facilitated antigen presentation (Sallusto et al,
1995; Tan et al, 1997; Buentke et al, 2000).
Extensive research has been carried out in the characterization of
MR on immature and mature DC derived from the pluripotent
peripheral blood monocytes by cell culture in granulocyte-
monocyte colony-stimulating factor (GM-CSF) and interleukin
(IL)-4. As a consequence, the expression of the MR has been
regarded a differentiation hallmark of immature DC, whereas
monocytes and mature DC do not express this structure (Cochand
et al, 1999; Sallusto et al, 1995; Mellman et al, 1998). A direct
relation of these observations to epidermal DC, and especially to
the altered situation of the epidermis in chronic in¯ammatory skin
diseases, however, had not been established.
In normal human skin, a single homogeneous cell population of
CD1a expressing, epidermally located, dendritically shaped, major
0022-202X/02/$15.00 ´ Copyright # 2002 by The Society for Investigative Dermatology, Inc.
327
Manuscript received August 14, 2001; revised October 16, 2001;
accepted for publication October 25, 2001.
Reprint requests to: Dr. Andreas Wollenberg, Department of
Dermatology, Ludwig-Maximilians-University, Frauenlobstr. 9±11, D-
80337 Munich, Germany. Email: wollenberg@lrz.uni-muenchen.de
Abbrevations: AD, atopic dermatitis; DC, dendritic cells; IDEC,
in¯ammatory dendritic epidermal cells; MoDC, monocyte-derived den-
dritic cells; MR, mannose receptor; Ps, psoriasis; rFI, relative ¯uorescence
index.
histocompatibility complex II positive DC containing Birbeck
granules has been thoroughly characterized. These are named after
Paul Langerhans (1847±1888), who discovered them in 1868
(Langerhans, 1868). Langerhans cells, when isolated from normal
human skin, are regarded as immature DC and are capable of
antigen uptake by pinocytosis. Upon activation by hapten or
isolation, these cells mature from good processors but weak
presenters of antigen to weak processors but good presenters of
antigen (Romani et al, 1989); therefore, one would expect
Langerhans cells to express the MR. Controversial data, however,
have been obtained about the expression of MR on Langerhans
cells from normal human skin (Noorman et al, 1997; Condaminet et
al, 1998; Mommaas et al, 1999).
In AD and other in¯ammatory skin diseases, a second CD1a+
epidermal DC population has been described, the so-called
in¯ammatory dendritic epidermal cells (IDEC) (Wollenberg et al,
1996). These cells are found in the epidermis in addition to
Langerhans cells in many chronic in¯ammatory skin diseases
(Wollenberg et al, 1999). Like Langerhans cells, the IDEC are
epidermally located, dendritically shaped, and express CD1a and
major histocompatibility complex II molecules. In contrast to
Langerhans cells, IDEC lack Birbeck granules and CD207
(Langerin, LAG antigen) (Wollenberg et al, 1996). The higher
CD1a expression of Langerhans cells allows a ¯ow cytometric
differentiation between Langerhans cells and IDEC (Wollenberg et
al, 1999). In AD, IDEC and not Langerhans cells are the relevant
IgE-binding, FceRI-expressing epidermal DC population
(Wollenberg et al, 1999).
In this study in normal and in¯amed human skin, we show that
IDEC, but not Langerhans cells are expressing the MR, and that
this receptor is functional in terms of receptor-mediated endocy-
tosis.
MATERIALS AND METHODS
Monocytes and monocyte-derived dendritic cell (MoDC) Freshly
isolated monocytes, as prepared from peripheral blood samples of healthy
volunteers by Ficoll density gradient centrifugation, were used as control
cells. Counterstaining was performed with a phycoerythrin-labeled anti-
CD14 MoAb Leu-M3 (IgG2b, Becton Dickinson, San Jose, CA) in a
®nal dilution of 1:300.
Immature MoDC were prepared from peripheral blood samples by
dextran sedimentation and subsequent cell culture in an IL-4 and GM-
CSF supplemented medium for 6 d, following the technique of Sallusto
and Lanzavecchia (1994). Counterstaining of the CD1a-positive MoDC
was performed with a phycoerythrin-labeled anti-CD1a monoclonal
antibody (MoAS) T6RD1 (IgG1, Coulter, Krefeld, Germany) in a ®nal
dilution of 1:300.
Skin biopsies Following written informed consent, skin biopsies were
obtained from patients of the Department of Dermatology and Allergy,
Ludwig-Maximilian-University, Munich (Germany), as approved by the
local ethics committee. After local anesthesia, biopsies were taken from
at least 2 wk untreated, chronic in¯ammatory skin lesions. Biopsies of
normal human skin obtained from surgical specimen served as control.
Analysis was performed on a total of 26 biopsies of normal human skin
(n = 8), AD (n = 5), and psoriasis vulgaris (n = 13).
Immunohistologic analysis with the alkaline-phosphatase mouse
anti-alkaline phosphatase technique Cryosections were prepared
from punch or shave biopsies, air-dried, ®xed for 10 min in pure
acetone, and then processed for immunohistochemistry using the MR-
speci®c MoAb D547 (IgG1, gift of A. Lanzavecchia, Basel, Switzerland)
at 10 mg per ml and the alkaline-phosphatase mouse anti-alkaline
phosphatase technique as described previously (Wollenberg et al, 1996).
The isotype matched MOPC-21 MoAb (Sigma, Deisenhofen, Germany)
was used as an isotype control.
Preparation and immunolabeling of epidermal cell
suspensions Epidermal single cell suspensions were prepared by a
standardized, limited trypsin digestion, ®ltered through a 50 mm nylon
mesh and stained for ¯ow cytometric analysis as described in detail
elsewhere (Wollenberg et al, 1999). Preliminary experiments performed
with MoDC showed that the MR expression was maintained after this
procedure, and that the MoDC were still taking up dextran ¯uorescein
isothiocyanate (FITC) by MR-mediated endocytosis (not shown).
Brie¯y, 2±5 3 105 epidermal cells were incubated in a polypropylene
tube with D547 in a ®nal concentration of 2 mg per ml for 30 min at
4°C in the dark, stained with a secondary polyclonal FITC-conjugated
goat anti-mouse antibody (Jackson, West Grove, PA) in a ®nal dilution
of 1:200 for 30 min at 4°C in the dark, blocked with normal mouse
serum and counterstained with the phycoerythrin-labeled anti-CD1a
MoAb T6RD1 (Wollenberg et al, 1999). For dead cell exclusion, 7-
amino-actinomycin-D was added in a ®nal concentration of 1 mg per ml
during the last antibody incubation (Wollenberg et al, 1999). In every
experiment, MOPC-21 MoAb was used as the appropriate isotype
control.
Flow cytometric analysis The washed cells were analyzed on a
FACScan (Becton Dickinson) employing the CellQuest software. A life
gate based on the physical properties of the cells (FSC vs SSC) was set to
exclude cell multiplets from acquisition. Vital CD1a+ epidermal DC
were gated out by a combination of a physical single cell gate (FSC vs
SSC) with a vital Langerhans cell gate (FL2 vs FL3) as described
(Wollenberg et al, 1999). For quantitative evaluation of receptor
expression, two-dimensional dot plot analysis was performed and all
CD1a+ cells, as well as the respective Langerhans cells and IDEC
populations were gated out manually. The mean ¯uorescence intensity
(MFI) of the FL-1-signal was determined and relative ¯uorescence
indices (rFI) of all surface receptors were calculated:
rFI = (MFI (receptor) ± MFI (control))/MFI (control)
This normalization procedure is important, as it makes the entire
procedure quite resistant against minor daily alterations (Wollenberg et al,
1999). For statistical evaluation, the Mann±Whitney U test was per-
formed. Results are shown as arithmetic mean 6 SEM.
Functional analysis of MR-mediated endocytosis The endocytotic
capacity of epidermal DC in suspension was analyzed with a receptor-
independent, unspeci®c probe for pinocytosis activity (Lucifer yellow)
and a second probe for MR-mediated endocytosis (dextran FITC) in a
technique following the protocol published by Sallusto et al (1995). As,
in addition to receptor-mediated endocytosis, there is some uptake of
dextran FITC by pinocytosis, preincubation with mannan (1.0 mg per
ml) was performed to block the MR-mediated endocytosis and delineate
MR-mediated endocytosis from the background ¯uorescence of dextran
FITC uptake by pinocytosis.
Cells were isolated from normal and in¯amed skin as described above
and cooled down in an ice water bath. Time course studies were
performed at 0, 3, 7, and 30 min by rewarming the cell suspensions in a
water bath to 37°C in the presence of Lucifer yellow (2.5 mg per ml) or
dextran FITC (1.0 mg per ml), or a 10 min preincubation with mannan
(1.0 mg per ml) followed by dextran FITC (1.0 mg per ml). For
quantitative evaluation of the receptor density, two-dimensional dot plot
analysis was performed for the respective monocyte, MoDC, Langerhans
cell, or IDEC populations analogous to the immunophenotyping of the
MR. Fluorescent dye uptake was quanti®ed by calculating rFI for the
different time points:
rFI = (MFI (0, 3, 7, 30 min) ± MFI (0 min))/MFI (0 min)
Electron microscopy and immunoelectron microscopy To analyze
cells by electron microscopy or immunoelectron microscopy, 4±5 3 106
epidermal cells were resuspended in 0.1% glutaraldehyde in 0.14 M
cacodylate buffer and ®xed for 1 h at room temperature. After washing
in phosphate buffer, half of the cells were processed for morphologic
investigation, the other half for immunoelectron microscopy. For
morphology, cells were post®xed in 1% OsO4 for 1 h at 4°C, pelleted in
2% agar, dehydrated in a graded ethanol series and embedded in Epon
(LX-112). Ultrathin sections were stained with uranyl acetate and lead
citrate. For immunoelectron microscopy cells were processed as
described elsewhere (Mommaas et al, 1992). Brie¯y, cells were pelleted
and embedded in 10% gelatin, cut into 1 mm2 cubes, cryoprotected in
2.3 M sucrose for 25 min, and snap frozen in liquid nitrogen. Ultrathin
cryosections were prepared and incubated with the mouse monoclonal
anti-MR antibody D547 (1:5) followed by rabbit anti-mouse IgG
(Dakopatts, Copenhagen, Denmark) and 10 nm protein A-gold. Primary
antibody was omitted or incubation with an irrelevant isotype-matched
antibody was performed as the control. After immunolabeling, sections
were embedded and contrasted in methylcellulose/uranyl acetate. All
specimens were viewed with a Philips EM 410 electron microscope.
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Cross-linking of the MR Cross-linking of the MR was performed
with immature MoDC on day 6 of culture in GM-CSF and IL-4 and
freshly isolated epidermal cell suspensions (see above). Cells were
cultured for an additional 24 h in the presence or absence of different
MR cross-linking agents and the appropriate control. The following
conditions were used: mannan (1 mg per ml), an untreated control
culture (nil), the D547 MoAb (2 mg per ml) followed by cross-linking
with a polyclonal goat anti-mouse antibody (Af®niPure-GaM-IgG-
(H + L), 50 mg per ml (Dianova, Hamburg, Germany) and the isotype
control antibody MOPC-21 followed by the polyclonal goat anti-mouse
antibody. DC maturation was assessed by immunophenotyping the
costimulatory molecules CD80 (MoAb L307.4, IgG1, Becton Dickinson)
and CD86 (MoAb IT2.2, IgG2b, Pharmingen, San Diego, CA), as well
as the CD83 molecule (HB15A, IgG2b, Immunotech, Marseille, France),
as indicated above. The MoAb against CD80 and CD86 do not show
any cross-reactivity to CD74, as has been described for other B7 MoAb
(Freeman et al, 1998).
RESULTS
In situ expression of the MR in in¯amed skin Cryosections of
normal human skin and lesional skin of psoriasis and AD were
immunostained with the MR-speci®c D547 MoAb in alkaline-
phosphatase mouse anti-alkaline phosphatase technique to identify
the morphology of the MR-expressing cells in situ and to localize
the MR-expressing cells in their epidermodermal context. In
normal human skin, some MR-positive cells could be detected
inside the dermis, but not inside the epidermis (not shown). In
contrast, many MR expressing cells were observed within dermis
and epidermis of psoriatic and AD skin (Fig 1a,b). Inside the
epidermal compartment, a membranous staining pattern of
dendritically shaped cells was seen in the suprabasal as well as the
basal layer of the epidermis. These results indicate that in¯amed,
but not normal human epidermis contains dendritically shaped
MR-expressing cells in situ. Staining with the isotype control
antibody MOPC-21 did not show any positive cells.
The expression of the MR is con®ned to IDEC Flow
cytometric analysis of epidermal cell suspensions was carried out to
identify the MR-expressing DC phenotype by double
immunostaining for CD1a+++ Langerhans cells and CD1a+
IDEC the MR expression on the DC surface. Normal human
skin did not reveal any cells reactive with the MR-speci®c antibody
D547 (Fig 2). In contrast, epidermal cell suspensions from
in¯ammatory skin lesions (AD, psoriasis) revealed two distinct
subsets of epidermal DC, independent of the underlying dermatosis
(Fig 2): A CD1a+++ population, which does not express MR, and
CD1a+ population, which expresses MR highly. The CD1a+++
population has been previously identi®ed as Langerhans cells
(Wollenberg et al, 1996), whereas the CD1a+ population
corresponds to the previously described IDEC (Wollenberg et al,
1996). A 24 h short-term culture of IDEC, known to induce
maturation of these cells, led to a 85% downregulation of MR on
IDEC (not shown). Thus, the MR expression was con®ned to the
IDEC population in all samples analyzed, as neither Langerhans
cells from normal human skin nor Langerhans cells from
in¯ammatory human skin expressed the MR (Fig 3). Control
experiments con®rmed that freshly isolated monocytes did not
express MR (Fig 2), whereas MoDC on day 6 of culture in IL-4
and GM-CSF stained positive for the MR (Fig 2).
MoDC in suspension take up dextran FITC from the
extracellular ¯uid To establish a clear test system for MR-
mediated endocytosis, MoDC on day 6 of culture in IL-4 and GM-
CSF were used as a positive control for dextran FITC uptake. The
morphology of dextran FITC positive MoDC was analyzed by
¯uorescence microscopy, revealing multiple ¯uorescent dots in
close conjunction to the cell membrane (not shown). MR-
mediated endocytosis, as assessed by uptake of dextran FITC by
MoDC, was demonstrated by ¯ow cytometric analysis (Fig 4a).
The receptor-mediated uptake of dextran FITC could be blocked
by the addition of mannan to the cell suspensions (Fig 4a). The
MR-independent uptake of the ¯uorescent dye Lucifer yellow, a
pinocytosis marker, was also demonstrated (Fig 4a). Time course
studies with monocytes and MoDC indicated a signi®cant dextran
FITC uptake by MoDC (Fig 4b, c), which could be blocked by
preincubation with mannan, whereas monocytes did not show a
signi®cant uptake of dextran FITC at all. This is in good
Figure 1. The MR is expressed in in¯amed human skin. Cryosections of lesional AD and psoriasis skin were immunostained in alkaline-
phosphatase mouse anti-alkaline phosphatase technique with the MR-speci®c MoAb D547. MR-expressing cells are visible inside the epidermal and
the dermal compartment of the in¯amed skin of both AD (a) and psoriasis (b), demonstrating the in situ expression of the MR.
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accordance with the results of the MR immunophenotype (Fig 2)
and demonstrates that the MR on MoDC is functional in terms of
antigen uptake by means of MR-mediated endocytosis.
IDEC take up dextran FITC by MR-mediated endocytosis
and pinocytosis To clarify whether the MR on IDEC is
functional in terms of receptor-mediated endocytosis, time course
studies of dextran FITC uptake were performed. Similar to MoDC,
freshly isolated IDEC showed a signi®cant uptake of dextran FITC
in a time-dependent manner (Fig 5a, c). By preincubation with
mannan, about half of the MR-mediated uptake of dextran FITC
could be blocked in the time course studies (Fig 5c). This is
witnessed by a slight shift of the dextran FITC histogram in the
presence of mannan (Fig 5a), whereas a stronger shift was seen
without the mannan preincubation. About half of the dextran
FITC uptake could not be blocked by mannan, however, thus
indicating a second, MR-independent pathway of uptake. This
other pathway might be based on the pinocytotic activity of IDEC,
which is demonstrated by the uptake of the pinocytosis dye Lucifer
yellow (not shown). Taken together, these results indicate the
coexistence of a MR-dependent and a MR-independent
mechanism of dextran FITC uptake in IDEC.
Langerhans cells take up dextran FITC by
pinocytosis Langerhans cells from normal and in¯amed skin
showed some uptake of dextran FITC in the time course studies,
but this uptake was almost identical in the absence and presence of
mannan (Fig 5b). Furthermore, Langerhans cells take up the
pinocytosis dye Lucifer yellow. These results are highly indicative
of a MR-independent pinocytotic uptake of dextran FITC into
Langerhans cells and correspond to the positive results obtained
with the pinocytosis dye Lucifer yellow in Langerhans cells
(Fig 5d).
IDEC show ultrastructural features of high endocytotic
activity Electron microscopic examination of epidermal DC,
which is known to distinguish Langerhans cells from IDEC by their
content of Birbeck granules (Wollenberg et al, 1996), was
performed to gain additional information about ultrastructural
signs of receptor-mediated endocytosis in IDEC. As expected from
previous studies, Langerhans cells with Birbeck granules (Fig 6a) as
well as IDEC without Birbeck granules were identi®ed in the cell
suspensions prepared from in¯amed skin of AD. Close to their cell
membrane, IDEC exhibited numerous clathrin-coated pits and
vesicles (Fig 6b), as observed in 50±100% of all IDEC. In contrast,
Langerhans cells never showed this phenomenon. The coated
vesicles made contact with larger endosome-like structures
(Fig 6c). This feature suggests fusion of the coated vesicles with
the larger endosome-like structures and a high endocytotic activity
of the IDEC.
Figure 2. Contour plot analysis of MR expression on different cell types. Epidermal cell suspensions were immunostained with the MR-speci®c
antibody D547 and an isotype control antibody. The cell populations of interest are gated out by coexpression of the respective lineage markers CD1a
or CD14. One representative of three experiments is shown. In normal, nonin¯amed human skin (normal skin), Langerhans cells are identi®ed by
double immunolabeling for their CD1a expression and do not express the MR. In untreated, lesional psoriasis skin (Ps skin), CD1a+++ Langerhans cells
and CD1a+ IDEC are identi®ed by double immunolabeling for their CD1a expression. CD1a+++ Langerhans cells do not express the MR, whereas
CD1a+ IDEC are expressing the MR. Atopic dermatitis lesions (AD skin) show the same results as psoriasis lesions. Freshly isolated monocytes
(monocytes), identi®ed by double immunolabeling for their CD14 expression, do not express the MR. Immature monocycle-derived dendritic cells,
analyzed on day 6 of culture in GM-CSF and IL-4, and identi®ed by double immunolabeling for their CD1a expression, are expressing the MR.
Figure 3. Expression of the MR on Langerhans cells and IDEC in
AD and psoriasis. Immunophenotyping of epidermal DC with the
MR-speci®c MoAb D547 in normal and in¯amed skin. MR expression
could not be detected on Langerhans cells isolated from normal skin
(n = 8), lesional AD skin (n = 5), or psoriasis vulgaris (n = 13). In
contrast, a high expression of the MR was found on IDEC, which are
exclusively present in in¯ammatory skin lesions. Receptor expression is
given as rFI for each cell population of interest.
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Immunogold staining of IDEC with the D547 MoAb showed
gold particles both on the cell surface and intracellularly, thereby
con®rming the results obtained by immunophenotyping (Fig 6d).
On the other hand, Birbeck granules were not found in any of the
MR-labeled cells.
Cross-linking of the MR does not in¯uence DC
maturation To investigate a possible in¯uence of MR cross-
linking on the maturation of DC, short-term culture with MR-
cross-linking agents was performed and the maturation markers
CD80, CD86, and CD83 were analyzed by ¯ow cytometry.
Independent of the cross-linking agents, the MoDC did not alter
their phenotype for any of the markers (not shown). Epidermal
DC, as isolated from in¯ammatory skin, showed the expected
maturation phenomenon upon isolation from the epidermis, as
witnessed by an upregulation of the expression of CD80, CD86,
and CD83; however, this upregulation occurred whether the MR
was cross-linked by a speci®c ligand or not. Hence, cross-linking of
the MR does not seem to in¯uence the maturation of either
MoDC or IDEC in culture.
DISCUSSION
Expression, regulation (Allavena et al, 1998; Longoni et al, 1998),
and function (Sallusto et al, 1995; Engering et al, 1997; Tan et al,
1997) of the MR have been studied on macrophages (Noorman et
al, 1997), monocytes (Noorman et al, 1997), immature and mature
MoDC (Sallusto et al, 1995; Noorman et al, 1997; Tan et al, 1997;
Kato et al, 2000), lung DC (Cochand et al, 1999), and epidermal
Langerhans cells either in situ or isolated from normal skin
(Condaminet et al, 1998; Mommaas et al, 1999; Kato et al, 2000).
Cells isolated from skin, bone marrow, thymus, lymph node, and
peripheral blood have been studied, and the expression of MR is an
accepted differentiation marker of immature MoDC. It is known
that the endocytosis of MR±antigen complexes into MoDC takes
place via small coated vesicles, delivering these complexes to the
major histocompatibility complex class II-enriched compartments
and lysosomes (Tan et al, 1997). IL-10 was shown to increase the
expression of MR on MoDC (Longoni et al, 1998), and MR-
mediated facilitated antigen presentation has been demonstrated in
MoDC (Engering et al, 1997; Tan et al, 1997); however, there have
Figure 4. MoDC take up dextran FITC by MR-mediated endocytosis. Time course study of pinocytosis and MR-mediated endocytosis by
MoDC. (a) Uptake of the pinocytosis marker Lucifer yellow and the MR-mediated endocytosis marker dextran FITC by immature MoDC (time
course study with 0, 3, 7, and 30 min incubation at 37°C). The preincubation of MoDC with mannan is blocking the MR-mediated endocytosis of
dextran FITC to the background level of ¯uid phase uptake. The amount of MR-mediated endocytosis may be assessed by subtraction of the
respective mean ¯uorescence intensities for dextran FITC uptake in the presence and absence of mannan. (b, c) Time course study of the uptake of the
MR-mediated endocytosis marker dextran FITC by freshly isolated monocytes and immature MoDC at 0, 3, 7, and 30 min incubation at 37°C. Mean
rFI values of a total of three experiments are shown. MoDC are showing a signi®cant MR-mediated endocytosis of dextran FITC at 7 and 30 min (*p
= 0.02), whereas freshly isolated monocytes do not.
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been no data available on epidermal DC from in¯ammatory skin
diseases.
The functional analysis of MR-mediated endocytosis in in¯amed
human skin is dif®cult to study, because: (i) for technical and ethical
reasons, there is very little material to work with; (ii) the MR-
speci®c uptake has to be identi®ed against a background of MR-
independent ¯uid phase uptake by Langerhans cells and IDEC; and
(iii) Langerhans cells and IDEC may mistakenly be analyzed as a
single cell type, if inappropriate methods are used. These problems
were overcome by performing each functional analysis in the
presence and absence of mannan and selectively gating out
CD1a+++ Langerhans cells and CD1a+ IDEC for each analysis by
means of their different CD1a expression as described (Wollenberg
et al, 1999). Thus, we could show for the ®rst time that IDEC are
Figure 5. IDEC take up dextran FITC by MR-mediated endocytosis. Time course study of MR-mediated endocytosis and pinocytosis by
Langerhans cells and IDEC. (a) Uptake of the MR-mediated endocytosis marker dextran FITC by IDEC (time course study with 0, 3, 7, and 30 min
incubation at 37°C). The dextran FITC uptake is strongest during the ®rst few minutes of incubation and may be inhibited by a preincubation with
mannan, thus indicating a MR-mediated endocytosis. (b) Time course study of the uptake of the MR-mediated endocytosis marker dextran FITC by
Langerhans cells at time point 0, 3, 7, and 30 min incubation at 37°C. Mean rFI values of a total of three experiments are shown. Langerhans cells
show some dextran FITC uptake, which occurs in the presence and absence of mannan, and is therefore indicative of a ¯uid phase uptake. (c) Time
course study of the uptake of the MR-mediated endocytosis marker dextran FITC by IDEC at time point 0, 3, 7, and 30 min incubation at 37°C.
Mean rFI values of a total of three experiments are shown. The uptake of dextran FITC by IDEC, which is signi®cant at 7 min (*p = 0.021), is partly
inhibited by a preincubation with mannan, demonstrating a mixed uptake by pinocytosis and MR-mediated endocytosis. (d) Time course study of the
uptake of the pinocytosis marker Lucifer yellow by IDEC, MoDC, Langerhans cells, and freshly isolated monocytes at time point 0, 7, 15, and 30 min
incubation at 37°C. Mean rFI values of a total of three experiments are shown, demonstrating a background of pinocytotic ¯uorescent dye uptake in all
of the cell types.
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expressing the MR, and that the MR on IDEC is involved in
receptor-mediated endocytosis.
As Langerhans cells are generally accepted to be an immature
epidermal DC population, one might expect that these cells should
express MR on their surface. The presence of MR on Langerhans
cells has been investigated, but are a matter of debate, as some
researchers identi®ed a mannose-binding activity on Langerhans
cells (Condaminet et al, 1998), whereas others were unable to ®nd a
MR on Langerhans cells in normal human skin (Noorman et al,
1997; Mommaas et al, 1999; Kato et al, 2000). In this study, we
could show that Langerhans cells do not express the MR and are
therefore, as expected, unable to take up the dextran FITC antigen
by MR-mediated endocytosis. This ®nding con®rmed the recent
results of Noorman et al (1997), Mommaas et al (1999), and Kato et
al (2000) obtained in normal human skin, and extends the lack of
MR expression to those Langerhans cells present inside an
in¯ammatory environment. The assumption of the MR being a
suitable differentiation marker for immature DC therefore seems
right for MoDC and various interstitial-type DC (Bell et al, 1999).
It does not need to apply to epidermal Langerhans cells, however,
as the latter are neither expressing the MR in situ nor following the
isolation procedure. One might even speculate that, ontogeneti-
cally, Langerhans cells may not be as closely related to MoDC as it
may be assumed (Caux et al, 1996; Strunk et al, 1997).
Furthermore, we could show for the ®rst time that in¯amed
human epidermis harbors a MR-expressing DC population, the so-
called IDEC (Wollenberg et al, 1996), and that the MR expressed
on IDEC is functional in terms of uptake of mannosylated antigens.
In contrast, our experimental set-up did not reveal a visible effect of
MR cross-linking on IDEC maturation. This does not, however,
exclude an effect of MR cross-linking on epidermal DC before
they have received a maturation stimulus, e.g., by an isolation
procedure. IDEC seem to be more closely related to the so-called
interstitial-type DC (Banchereau and Steinman, 1998) than to
Langerhans cells. This is witnessed by the immunogold labeling
results with a MR-speci®c antibody on IDEC, which displayed a
similar distribution pattern of gold particles as was found previously
for MoDC (Tan et al, 1997), although the labeling intensity was less
pronounced. It is already known that IDEC are present in
in¯ammatory but not in normal human skin and that IDEC and
not Langerhans cells are the relevant IgE-binding and FceRI-
expressing epidermal DC population in AD (Wollenberg et al,
1996, 1999). The ontogenesis of IDEC is still unclear, but a
monocyte-derived origin is an attractive hypothesis. The demon-
stration of MR on IDEC in situ and freshly isolated IDEC, as well
as the downregulation of MR during short-term culture of IDEC
both resemble the characteristics of MR expression on MoDC and
support the view that IDEC may be a monocyte-derived immature
DC of the interstitial type (Banchereau and Steinman, 1998; Bell et
al, 1999). We did not study the regulation of MR on IDEC, but it
is known from other cell systems that IL-10 and glucocorticoids
increase the MR expression and MR-mediated endocytotic activity
in these cells (Longoni et al, 1998; Piemonti et al, 1999).
The expression of MR in an epidermal DC population has
biologic signi®cance, as the MR is not only a differentiation marker
of an interstitial DC population inside the in¯amed epidermis, but
Fig. 6 IDEC show ultrastructural features of high endocytotic activity. Electron micrographs of details of Langerhans cells and IDEC processed
for morphologic (a±c) or immunogold (d) investigation. (a) Langerhans cells are containing several typical Birbeck granules (small arrows). (b) An IDEC
reveals the formation of coated (large arrow) and uncoated pits protruding from the cell membrane. (c) Higher magni®cation of the cytoplasm of an
IDEC shows the formation of numerous coated pits and vesicles, which are seemingly fusing with larger, endosome-like structures. These
ultrastructural ®ndings are suggestive of a high endocytotic activity of the IDEC. (d) Ultrathin cryosections of IDEC that were stained for the MR
showed gold labeling on the cell surface and intracellularly (small arrowheads); scale bar: 0.25 mm.
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may play an important part in the capture of mannosylated antigens
for subsequent antigen presentation and immunity (Sallusto et al,
1995). In AD, MR-mediated endocytosis might contribute to a
facilitated antigen presentation process of various glycoprotein
allergens (Bieber, 1997) analogous of the MR-mediated facilitated
antigen presentation shown in other DC (Tan et al, 1997).
Furthermore, epidermal DC expressing the MR might play a part
in the defense of psoriatic and AD skin against colonization with
mannose-rich pathogens, e.g., fungi and bacteria. The recently
demonstrated MR-mediated interaction and uptake of Malassezia
furfur yeast cells, an important allergen in AD patients, by immature
MoDC emphasizes the clinical relevance of MR expression in AD
skin in vivo (Buentke et al, 2000).
It can be concluded that (i) Langerhans cells and IDEC are
distinct cell populations in term of their endocytotic mechanisms,
and (ii) that the MR may be a suitable maturation marker of
interstitial-type DC, such as MoDC, but not of Langerhans cells.
Furthermore, our ®ndings support the hypothesis that IDEC may
be a monocyte-derived immature DC of the interstitial type
(Banchereau and Steinman, 1998).
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